Wumaier Reziya, Zhang Ke, Zhou Jing, Wen Zilu, Chen Zihan, Luo Geyang, Wang Hao, Qin Juliang, Du Bing, Ren Hua, Song Yanzheng, Gao Qian, Yan Bo
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Shanghai Public Health Clinical Center, Fudan University, Shanghai 200433, China.
Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Microorganisms. 2025 Jan 8;13(1):110. doi: 10.3390/microorganisms13010110.
Tuberculosis (TB) remains the major cause of mortality and morbidity, causing approximately 1.3 million deaths annually. As a highly successful pathogen, () has evolved numerous strategies to evade host immune responses, making it essential to understand the interactions between and host cells. G-protein-coupled receptor 84 (GPR84), a member of the G-protein-coupled receptor family, contributes to the regulation of pro-inflammatory reactions and the migration of innate immune cells, such as macrophages. Its role in mycobacterial infection, however, has not yet been explored. We found that GPR84 is induced in whole blood samples from tuberculosis patients and )-infected macrophage models. Using a infection model in mouse tails, we found that GPR84 is an important determinant of the extent of tissue damage. Furthermore, from our studies in an in vitro macrophage infection model, it appears that GPR84 inhibits pro-inflammatory cytokines expression and increases intracellular lipid droplet (LD) accumulation, thereby promoting intracellular bacterial survival. Our findings suggest that GPR84 could be a potential therapeutic target for host-directed anti-TB therapeutics.
结核病(TB)仍然是导致死亡和发病的主要原因,每年造成约130万人死亡。作为一种非常成功的病原体,()已经进化出多种策略来逃避宿主的免疫反应,因此了解()与宿主细胞之间的相互作用至关重要。G蛋白偶联受体84(GPR84)是G蛋白偶联受体家族的成员之一,有助于调节促炎反应和先天免疫细胞(如巨噬细胞)的迁移。然而,其在分枝杆菌感染中的作用尚未得到探索。我们发现,GPR84在结核病患者的全血样本和()感染的巨噬细胞模型中被诱导。使用小鼠尾部的()感染模型,我们发现GPR84是组织损伤程度的一个重要决定因素。此外,从我们在体外巨噬细胞()感染模型中的研究来看,GPR84似乎抑制促炎细胞因子的表达并增加细胞内脂滴(LD)的积累,从而促进细胞内细菌的存活。我们的研究结果表明,GPR84可能是宿主导向性抗结核治疗的一个潜在治疗靶点。